CELLDEX THERAPEUTICS INC (CLDX:NASDAQ)
$41.22 0.65 (1.6022%)
Analysed CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) News Sources
Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting
14-06-2026
yahoo.com
Chronic Spontaneous Urticaria Market Heats Up as Pharma Companies Race to Address Unmet Needs | DelveInsight
24-06-2026
yahoo.com
Celldex Announces Planned Transition of Chief Financial Officer
15-07-2026
yahoo.com
CLDX Stock Down 10% After-Hours — What’s Driving The Selloff?
21-07-2026
stocktwits.com
Summit counters PD-1/VEGF skeptics; Celldex drug fails skin disease study
22-07-2026
biopharmadive.com
Celldex Therapeutics Scraps PN Plans After Barzolvolimab Phase 2 Miss
22-07-2026
marketbeat.com
Are Medical Stocks Lagging Celldex Therapeutics (CLDX) This Year?
24-07-2026
yahoo.com
Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates
06-08-2026
yahoo.com
Celldex Therapeutics (CLDX) Stock Trades At A Premium Despite A 102% Return
09-08-2026
yahoo.com
Celldex Therapeutics (CLDX) Could Be 130% Undervalued After Second Quarter Results
09-08-2026
yahoo.com
What is the current price of CELLDEX THERAPEUTICS INC (CLDX:NASDAQ)?
The current price of CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) is $41.22.
CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) absolute price change since previous trading day?
The absolute price change of CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) since the previous trading day is $0.65.
CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) percentage price change since previous trading day?
The percentage price change of CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) since the previous trading day is 1.6022%.
What is the most recent average sentiment score for CELLDEX THERAPEUTICS INC (CLDX:NASDAQ)?
The most recent average sentiment score for CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) is 59 out of 100.
What is the most recent average sentiment for CELLDEX THERAPEUTICS INC (CLDX:NASDAQ)?
The most recent sentiment for CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) is .
SEC-8K** Filing Available For CELLDEX THERAPEUTICS INC (CLDX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.